DTL
AGIO icon

Dynamic Technology Lab’s Agios Pharmaceuticals AGIO Stock Holding History

Dynamic Technology Lab’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,190
Closed -$335K – 1061
2021
Q4 		$335K Buy
+10,190
New +$410K 0.04% 759
2021
Q3 		– Sell
-5,790
Closed -$319K – 1027
2021
Q2 		$319K Buy
+5,790
New +$324K 0.03% 765
2018
Q3 		– Sell
-7,979
Closed -$672K – 990
2018
Q2 		$672K Buy
+7,979
New +$696K 0.1% 335

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Dynamic Technology Lab's AGIO Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Agios Pharmaceuticals (AGIO) in Q1 2022, closing a stake of 10,190 shares — an estimated $335K sold.

Dynamic Technology Lab first reported a position in AGIO in Q2 2018 and held it in 3 quarters. The position peaked at $672K in Q2 2018. 161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Dynamic Technology Lab reported no remaining Agios Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 10,190 Agios Pharmaceuticals shares in Q1 2022, an estimated $335K.
  • Dynamic Technology Lab first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Dynamic Technology Lab's Agios Pharmaceuticals position peaked at $672K in Q2 2018.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.